{"result": "(\"entity\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Sociedad Española de Endocrinología y Nutrición (SEEN) is an organization that provides guidelines and recommendations for the management of metabolic bone disease associated with home parenteral nutrition.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>EVENT<|>Home parenteral nutrition (NPD) is a medical treatment for patients who cannot obtain adequate nutrition through oral intake, often involving intravenous delivery of nutrients.)\n##\n(\"entity\"<|>REYES GARCÍA R<|>PERSON<|>Reyes García R is one of the authors of the clinical practice guidelines for the evaluation and treatment of osteoporosis associated with endocrine and nutritional diseases.)\n##\n(\"entity\"<|>JÓDAR GIMENO E<|>PERSON<|>Jódar Gimeno E is one of the authors of the clinical practice guidelines for the evaluation and treatment of osteoporosis associated with endocrine and nutritional diseases.)\n##\n(\"entity\"<|>GARCÍA MARTÍN A<|>PERSON<|>García Martín A is one of the authors of the clinical practice guidelines for the evaluation and treatment of osteoporosis associated with endocrine and nutritional diseases.)\n##\n(\"entity\"<|>ROMERO MUÑOZ M<|>PERSON<|>Romero Muñoz M is one of the authors of the clinical practice guidelines for the evaluation and treatment of osteoporosis associated with endocrine and nutritional diseases.)\n##\n(\"entity\"<|>GÓMEZ SÁEZ JM<|>PERSON<|>Gómez Sáez JM is one of the authors of the clinical practice guidelines for the evaluation and treatment of osteoporosis associated with endocrine and nutritional diseases.)\n##\n(\"entity\"<|>LUQUE FERNÁNDEZ I<|>PERSON<|>Luque Fernández I is one of the authors of the clinical practice guidelines for the evaluation and treatment of osteoporosis associated with endocrine and nutritional diseases.)\n##\n(\"entity\"<|>VALORACIÓN GLOBAL SUBJETIVA GENERADA POR EL PACIENTE<|>EVENT<|>The Global Subjective Assessment Generated by the Patient (VGS-GP) is a nutritional screening tool specifically designed for oncology patients to assess their nutritional status.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Enteral nutrition is a method of delivering nutrients directly into the gastrointestinal tract, often used for patients who cannot eat by mouth.)\n##\n(\"relationship\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>The Sociedad Española de Endocrinología y Nutrición provides guidelines for the management of conditions related to home parenteral nutrition.<|>8)\n##\n(\"relationship\"<|>REYES GARCÍA R<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Reyes García R is an author of the guidelines published by the Sociedad Española de Endocrinología y Nutrición.<|>7)\n##\n(\"relationship\"<|>JÓDAR GIMENO E<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Jódar Gimeno E is an author of the guidelines published by the Sociedad Española de Endocrinología y Nutrición.<|>7)\n##\n(\"relationship\"<|>GARCÍA MARTÍN A<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>García Martín A is an author of the guidelines published by the Sociedad Española de Endocrinología y Nutrición.<|>7)\n##\n(\"relationship\"<|>ROMERO MUÑOZ M<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Romero Muñoz M is an author of the guidelines published by the Sociedad Española de Endocrinología y Nutrición.<|>7)\n##\n(\"relationship\"<|>GÓMEZ SÁEZ JM<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Gómez Sáez JM is an author of the guidelines published by the Sociedad Española de Endocrinología y Nutrición.<|>7)\n##\n(\"relationship\"<|>LUQUE FERNÁNDEZ I<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Luque Fernández I is an author of the guidelines published by the Sociedad Española de Endocrinología y Nutrición.<|>7)\n##\n(\"relationship\"<|>VALORACIÓN GLOBAL SUBJETIVA GENERADA POR EL PACIENTE<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>The Global Subjective Assessment Generated by the Patient is a tool used in the context of home parenteral nutrition to assess nutritional status.<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>Enteral nutrition is an alternative nutritional approach that may be considered for patients who are also receiving home parenteral nutrition.<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: enfermedad metabólica ósea en pacientes con nutrición parenteral domiciliaria es del 30-60%, y esta puede presentarse como osteomalacia, osteopenia y osteoporosis. Los estudios realizados muestran, además, una elevada prevalencia de fracturas (10-40%) y una evolución heterogénea de la densidad mineral ósea (DMO) durante el seguimiento.\n\nLa Sociedad Española de Endocrinología y Nutrición (SEEN) hace las siguientes recomendaciones acerca del manejo de la enfermedad metabólica ósea asociada a la nutrición parenteral:\n\n- Evaluar la DMO al incluir a un paciente en un programa de nutrición parenteral domiciliaria (NPD) si el pronóstico vital del enfermo lo justifica.\n- Realizar un diagnóstico diferencial entre osteopenia/osteoporosis y osteomalacia en pacientes con baja DMO, especialmente a la hora de plantear una terapia.\n- Sugerimos realizar una evaluación periódica (cada 1-2 años) de la DMO en los pacientes con NPD si el pronóstico del paciente lo justifica.\n- Evaluar las concentraciones de 25-OH-vitamina D en pacientes que sean incluidos en un programa de NPD.\n- Sugerimos plantear un tratamiento farmacológico en aquellos pacientes con NPD y afectación ósea si el pronóstico vital lo justifica.\n- Garantizar un adecuado aporte de vitamina D por vía oral o parenteral dada la elevada prevalencia de deficiencia de vitamina D y la habitual coexistencia de malabsorción en estos pacientes (RDA 600-800 UI/día).\n- En pacientes con NPD y osteoporosis sugerimos considerar los bifosfonatos intravenosos o denosumab como una opción terapéutica.\n- En pacientes con larga expectativa de vida, sugerimos tratar con anabólicos en caso de fracturas por fragilidad o mala respuesta al tratamiento con anticatabólicos.\n\nReferencias:\n- Reyes García R, Jódar Gimeno E, García Martín A, Romero Muñoz M, Gómez Sáez JM, Luque Fernández I, et al; Grupo de Metabolismo Mineral de la Sociedad Española de Endocrinología y Nutrición. Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales. Endocrinol Nutr. 2012;59(3):174-96.\n\n## 4.8 Casos clínicos. Caso clínico 2\n\n### 54. Aunque los siguientes métodos están validados en cribado de riesgo nutricional en el paciente hospitalizado, ¿cuál de entre ellos está validado especialmente en el paciente oncológico?\n\nA. Nutritional Risk Screening (NRS) 2002.\nB. Malnutrition Universal Screening Tool (MUST).\nC. Valoración Global subjetiva Generada por el paciente (VSGGP).\nD. Mini-Nutritional Assessment (MNA).\n\n### COMENTARIO\n\nEl cribado nutricional se define como el proceso que permite identificar a los individuos desnutridos, o en riesgo de desnutrición, y determinar si precisan una evaluación nutricional más detallada.\n\nLa valoración global subjetiva generada por el paciente (VGS-GP):\n\n- Es una variación de la valoración global subjetiva original, en la que el paciente cubre los datos de la historia clínica y el médico, la exploración física, y un apartado sobre enfermedad y tratamiento neoplásico.\n- Se clasifica a los pacientes en tres categorías: bien nutridos (A), moderadamente desnutridos (B) y gravemente desnutridos (C). Se obtiene una puntuación que va a determinar la necesidad o no de tratamiento.\n- Está diseñada específicamente para el paciente oncológico (hospitalizado o ambulatorio). El tiempo de realización para ser cumplimentada en parte por el paciente es bajo.\n\nReferencias:\n- Álvarez C, Ocón-Bretón MJ, Luengo Pérez LM, Viruzuela JA, Sendrós Maroño MJ, Cervera Peris M, et al. Soporte nutricional y nutrición parenteral en el paciente oncológico: informe de consenso de un grupo de expertos. Nutr Hosp. 2018;35(1):224-33.\n- Martínez Olmos MA, Villar Taibo R. Valoración del estado nutricional. Manual de Endocrinología y Nutrición. Sociedad Española de Endocrinología y Nutrición. 2016. Disponible en: https://manual.seen.es.\n---\nNUTRICIÓN 4\n\n## 55. En el tratamiento se deja prescrita dieta líquida, analgesia y sueroterapia con 1.500 ml de suero glucosalino. Tras la valoración nutricional, ¿qué intervención nutricional terapéutica inicial le parece la más adecuada?\n\nA. Indicar nutrición enteral completa por vía oral hasta la cirugía y revisar evolución pasadas 48 horas.\nB. Indicar nutrición enteral completa a través de sonda nasogástrica, ya\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}